Hype is a great product in the short term, but it’s pretty expensive. When Amyris(NASDAQ:AMRS) reported second-quarter and first-half 2020 operating results, it directed investors to a handful of che…
Read More
Amyris Reports Its Largest First-Half Operating Loss Since 2012
